1
1
0
Metformin is a type 2 Diabetes treatment drug.
A commonly prescribed medication used to treat type 2 diabetes is facing a recall due to the presence of a potentially cancer-causing substance.
Viona Pharmaceuticals has voluntarily recalled 33 batches of its Metformin Hydrochloride Extended-Release 750 mg tablets sold in 100-count bottles with expiration dates ranging from June 2022 to March 2023, the Food and Drug Administration (FDA) announced on Dec. 28. N-Nitrosodimethylamine (NDMA), a probable human carcinogen, was detected during testing.
A commonly prescribed medication used to treat type 2 diabetes is facing a recall due to the presence of a potentially cancer-causing substance.
Viona Pharmaceuticals has voluntarily recalled 33 batches of its Metformin Hydrochloride Extended-Release 750 mg tablets sold in 100-count bottles with expiration dates ranging from June 2022 to March 2023, the Food and Drug Administration (FDA) announced on Dec. 28. N-Nitrosodimethylamine (NDMA), a probable human carcinogen, was detected during testing.
Diabetes Drug Recalled Due to Risk of Cancer
Posted from aarp.org
Drugs
Cancer
Posted 3 y ago
Responses: 1
Read This Next
Continue with Facebook 
Continue with Google